Between 16 March and 14 June 2024, 42 highly pathogenic avian influenza (HPAI) A(H5) virus detections were reported in domestic (15) and wild (27) birds across 13 countries in Europe.
This technical report is a laboratory manual that accompanies the ‘Survey protocol for the ECDC genomic-based surveillance of carbapenem-resistant Acinetobacter baumannii in Europe’.
This ECDC survey protocol describes the technical requirements for implementing a genomic surveillance-based survey of CRAb isolates from patients seeking hospital care. It is intended for first use in 2024–2025.
ECDC launches a protocol for a genomic survey of carbapenem-resistant Acinetobacter baumannii (CRAb) across hospitals from EU/EEA countries, Western Balkan countries and Türkiye.
Since the beginning of 2024, over 10 million dengue cases and over 5 000 dengue-related deaths have been reported from 80 countries/territories. Most cases globally have been reported from the WHO PAHO region.
ECDC regularly assesses new evidence on variants detected through epidemic intelligence, rules-based genomic variant screening or other scientific sources.